MALE YEAST INFECTION Its CAUSE, TREATMENT,
SYMPTOMS, PICTURES, CURE, REMEDY, PHOTOS and PICS
Its CAUSE, TREATMENT,
SYMPTOMS, PICTURES, CURE, REMEDY, PHOTOS and PICS
|
Clinical evaluation of combined use of the spermicide Nonoxynol-9 and condoms
De Andrea Filho A, Marziona F. PIP: Condoms represent an efficient family planning method. Their use was 1st described by the Italian anatomist Fallopio in 1564. Their effectiveness is considered to result in 0.5-2 births/100 years of marriage. 1st descriptions of vaginal contraceptives, by the Egyptians, date back to 1850 B.C. Their effectiveness is considered to be 5-10/100 years of marriage. A combined usage of condom and spermicides such as Nonoxynol-9 could thus elevate contraceptive effectiveness more than 20 times. A clinical test of such a combination product was conducted involving 2 groups consisting of 30 women each (1 control group) in order to evaluate possible alterations in vaginal mucus. By using questionnaires, women with a history of allergy to condoms or vaginal creams were excluded. However, those with symptoms of vulvovaginitis were not. The 2 groups were subjected to laboratory tests before and after usage: bacterioscopy, culture of vulvovaginal secretions, the saline drop method in order to diagnose Trichomonas, and the potassium hydroxide drop method in order to diagnose Gardnerella vaginalis and Candida albicans. Vaginal colposcopy and measuring of vulvovaginal pH were also performed. The results, before and after use, are listed for both groups in 3 tables, with reference to 2 clinical symptoms (itching of burning sensation), vaginal pH (normal, above, below), and various microorganisms being isolated. The tables do not allow for any interpretation of significant alterations resulting from the use of the combination product, e.g., the elevation of pH in some cases and 1 failure should be attributed to variations of flora not caused by the product, but being due to chance variations occurring in any given population. The absence of traumatic factors is due to the vaginal structure being functionally adapted, with numerous folds and wrinkles, to coitus. The effectiveness of the product is well documented in literature, and data listing decreased sperm motility is presented. It is concluded that no clinical adverse effects result with reference to the vulvovaginal epithelium or the penis. MeSH Terms: Substances: |
. |
